Physician

Fadi H Delly, M.D.

According to 2025 Medicare claims, Fadi Delly, M.D. (NPI: 1104137967) practices neurology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is FADI DELLY, MD PC (NPI: 1992170187; TIN: 475587852) and primary practice location at 48195-2378. Delly is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Delly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,105 traditional Medicare patients, billed 17,373 HCPCS/CPT codes, and received $633,228 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,562 prescription claims across 809 beneficiaries totaling $286,505 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). 2020 DME data shows 12 claims. Open Payments data shows 190 records totaling $3,893. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $57,062 to $633,228. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $36,528 and ending at $286,505. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	254	645	$57,062
2016	496	2,861	$147,950
2017	753	8,329	$339,155
2018	886	8,628	$357,086
2019	886	8,874	$390,530
2020	849	8,567	$377,053
2021	905	8,588	$421,874
2022	933	10,163	$470,755
2023	977	12,707	$476,345
2024	1,105	17,373	$633,228

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	89	441	$36,528
2016	391	1,749	$259,712
2017	648	5,027	$432,380
2018	727	4,483	$412,848
2019	640	3,454	$362,292
2020	603	2,900	$180,691
2021	689	2,807	$109,743
2022	713	2,509	$164,536
2023	807	3,052	$416,757
2024	809	2,562	$286,505

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$496
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	520	1,238	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	360	577	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	489	891	$13
96372	Injection of drug or substance under skin or into muscle	370	1,023	$11
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	270	2,072	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	11	316	$11,986
Gabapentin	Gabapentin	626	23,242	$5,257
Lidocaine	Lidocaine	31	1,000	$2,741
Pregabalin	Pregabalin	151	5,079	$2,348
Carbidopa-Levodopa	Carbidopa/Levodopa	79	4,590	$2,227

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	190	$3,893	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fadi H. Delly, M.D.?

Tedicare shows public-source Medicare data for Fadi H. Delly, M.D. (NPI 1104137967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fadi H. Delly, M.D. have ACO affiliation data?

Fadi H. Delly, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Fadi H. Delly, M.D.?

Fadi H. Delly, M.D. is linked to FADI DELLY, MD PC (billing NPI 1992170187) in the available physician profile data.

Does Fadi H. Delly, M.D. have Open Payments data?

Fadi H. Delly, M.D. has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.